Analyst Research: Ranbaxy Laboratories Ltd (RBXZF.PK)

RBXZF.PK on OTC Markets Group - US Other OTC and Grey Market

9.80USD
17 Sep 2014
Price Change (% chg)

$-0.60 (-5.77%)
Prev Close
$10.40
Open
$9.80
Day's High
$9.80
Day's Low
$9.80
Volume
1,400
Avg. Vol
25
52-wk High
$10.50
52-wk Low
$5.10

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Ranbaxy Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 19 Sep 2014 Reuters Investment Profile 12 20.00
Thomson Reuters Stock Report - RANBAXY LABORATORIES LIMITED (RANBAXY-IN) 19 Sep 2014 Thomson Reuters Stock Report 11 25.00
Wright Investors Service Comprehensive Report for Ranbaxy Laboratories Limited 24 Aug 2014 Wright Reports 56 75.00
MOSL: RANBAXY LABS (Buy) - Core profitability surprises positively, early signs of core margin recovery 30 Jul 2014 Motilal Oswal Securities Ltd. 8 81.00
Ranbaxy Labs (RBXY) - Qtr. Update - Dated - July 29, 2014 29 Jul 2014 Axis Capital Limited 4 35.00
Ranbaxy - Q1FY15 Result Update - "HOLD" 29 Jul 2014 Kisan Ratilal Choksey Shares and Securities Private Limited 6 58.00
Ranbaxy Laboratories falls for a second consecutive day, a two-day fall of 0.4% 10 Jul 2014 BuySellSignals Research 15 5.00
 
Name Age Since Current Position

Tsutomu Une

65 2009 Non-Executive Non-Independent Chairman of the Board

Indrajit Banerjee

56 2011 President, Chief Financial Officer

Arun Sawhney

2011 Chief Executive Officer, Managing Director, Executive Director

Rajiv Gulati

President - Global Pharmaceuticals Business

Dale Adkisson

Executive Vice President, Head - Global Quality
Search Stocks